CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting
On May 9, 2025, CME Group Inc., recognized as a leader in global derivatives markets, shared the preliminary results of shareholder voting at their annual meeting. Key highlights from the meeting indicate significant decisions and appointments for the company moving forward.
Election of Directors
A major focus of the meeting was the election of board members. Shareholders cast their votes to elect a slate of directors for a one-year term that will conclude in 2026. The elected individuals include:
- - Terrence A. Duffy
- - Kathryn Benesh
- - Timothy S. Bitsberger
- - Charles P. Carey
- - Bryan T. Durkin
- - Harold Ford Jr.
- - Martin J. Gepsman
- - Daniel G. Kaye
- - Phyllis M. Lockett
- - Deborah J. Lucas
- - Rahael Seifu
- - William R. Shepard
- - Howard J. Siegel
- - Dennis A. Suskind
However, during the elections for the Class B directorships, quorum issues resulted in some current board members continuing in their roles until successors can be properly voted in at the 2026 meeting. The continuation of the following members was thus confirmed:
- - Class B-1: William W. Hobert, Patrick J. Mulchrone, Robert J. Tierney Jr.
- - Class B-2: Patrick W. Maloney.
- - Class B-3: Elizabeth A. Cook.
Ratification of Accounting Firm
Another important vote taken during the annual meeting was the ratification of
Ernst & Young LLP as the company's independent registered public accounting firm for the year 2025. This confirmation underscores the company’s commitment to maintaining the highest standards in financial reporting and accountability.
Compensation Advisory Vote
Shareholders also participated in an advisory vote regarding the compensation of the company’s named executive officers. While this vote does not carry binding authority, it highlights stakeholder sentiment regarding leadership compensation.
Next Steps and Final Results
CME Group indicated that the final results, including detailed voting percentages for each proposal, would be disclosed in a formal report filed with the Securities and Exchange Commission. The transparency in reporting aligns with the company’s values of open governance and accountability.
CME Group's Role in the Market
As a front-runner in the derivatives marketplace, CME Group offers a wide array of trading solutions, including futures and options across multiple asset classes such as interest rates, equity indexes, and commodities. Through platforms like CME Globex and BrokerTec, the company empowers market participants to manage risk effectively while capturing opportunities in the financial landscape.
With its extensive global reach and commitment to innovation, CME Group continues to play a vital role in driving efficiencies in the financial markets. For more information, interested parties can visit
CME Group's official website.
In summary, the 2025 annual meeting not only solidified the board’s leadership but also affirmed CME Group’s ongoing commitment to sound governance and strategic financial management.